AXA IM Alts raises €1.9b for European life sciences investments

AXA IM Alts, the alternative investments manager, has raised €1.9 bn of equity to accelerate investments into the Life Sciences sector.

Premium subscriber content – please log in to read more or take a free trial.

Events

Latest news

Best read stories